<p>Aveanna Healthcare Holdings Inc.（NASDAQ:AVAH - 獲取免費報告）的股票被十家研究公司一致推薦為 “持有”，Marketbeat Ratings 報告稱。六位分析師對該股票給予了持有評級，四位分析師則給予了買入評級。在過去一年中更新了對該股票覆蓋的分析師中，平均 12 個月目標價為 10.1875 美元。</p>
<p>最近，一些分析師對該公司發佈了報告。瑞銀集團將 Aveanna Healthcare 的目標價從 9.00 美元上調至 9.50 美元，並在 11 月 7 日的研究報告中給予該股票 “中性” 評級。加拿大皇家銀行在 10 月 24 日的研究報告中將 Aveanna Healthcare 的目標價從 8.00 美元上調至 10.00 美元，並給予該股票 “行業表現” 評級。巴克萊在 8 月 19 日的報告中將 Aveanna Healthcare 的評級從 “持平” 上調至 “超配”，並將該公司的目標價從 5.50 美元上調至 9.50 美元。摩根大通在 9 月 18 日的研究報告中將 Aveanna Healthcare 的評級從 “減持” 上調至 “中性”，並將該公司的目標價從 6.00 美元上調至 10.00 美元。最後，BMO 資本市場在 11 月 13 日的研究報告中開始覆蓋 Aveanna Healthcare，並設定了 “跑贏大盤” 的評級和 11.00 美元的目標價。</p>
<p>獲取 <strong>Aveanna Healthcare</strong> 的提醒：</p>
<p><strong>查看我們最新的 AVAH 股票報告</strong></p>
<h2>內部買賣</h2>
<p>在其他消息中，主要股東 J.H. Whitney Equity Partners V 在 10 月 21 日的交易中出售了 8,346,059 股公司的股票。股票以平均價格 9.00 美元出售，總價值為 75,114,531.00 美元。出售完成後，該內部人士在公司中持有 20,544,696 股，估值約為 184,902,264 美元。此次交易使其持股減少了 28.89%。該交易在向 SEC 提交的文件中披露，可以通過此超鏈接訪問。此外，主要股東 Paul R. Vigano 在 10 月 21 日的交易中出售了 10,000,000 股 Aveanna Healthcare 的股票。股票以平均價格 9.00 美元出售，總交易額為 90,000,000.00 美元。交易完成後，該內部人士直接持有 386,284 股，估值約為 3,476,556 美元。此次交易使其持股減少了 96.28%。SEC 對此次出售的文件提供了更多信息。內部人士在上個季度共出售了 32,597,968 股公司股票，價值 293,381,712 美元。公司內部人士持有 7.80% 的股票。</p>
<h2>機構資金流入和流出</h2>
<p>一些機構投資者和對沖基金最近調整了對該公司的持股。Summit Partners L P 在第二季度收購了 Aveanna Healthcare 的新股份，價值約為 50,477,000 美元。AustralianSuper Pty Ltd 在第三季度收購了 Aveanna Healthcare 的股份，價值約為 15,743,000 美元。先鋒集團在第三季度將其在 Aveanna Healthcare 的股份增加了 34.7%。先鋒集團現在持有 4,041,659 股公司的股票，價值為 35,850,000 美元，此前在該期間內又收購了 1,041,324 股。Hillsdale Investment Management Inc.在第三季度收購了 Aveanna Healthcare 的新股份，價值約為 7,922,000 美元。最後，Assenagon Asset Management S.A.在第三季度收購了 Aveanna Healthcare 的股份，價值約為 7,356,000 美元。對沖基金和其他機構投資者持有公司 87.96% 的股票。</p>
<h2>Aveanna Healthcare 股票表現</h2>
<p>NASDAQ:AVAH 的股票在週五開盤價為 9.32 美元。該公司的 50 日簡單移動平均為 9.03 美元，200 日簡單移動平均為 6.90 美元。公司的速動比率為 1.23，流動比率為 1.23，債務與股本比率為 140.39。該股票的市值為 19.5 億美元，市盈率為 25.88，貝塔值為 2.04。Aveanna Healthcare 的 52 周最低價為 3.67 美元，52 周最高價為 10.32 美元。</p>
<p>Aveanna Healthcare（NASDAQ:AVAH - 獲取免費報告）最後一次公佈季度財報是在 5 月 22 日，報告顯示該季度每股收益為 0.04 美元。該公司在該季度的收入為 4.5053 億美元。Aveanna Healthcare 的淨利潤率為 3.29%，股本回報率為負的 143.55%。分析師平均預計 Aveanna Healthcare 在當前財年將發佈-0.06 的每股收益。</p>
<h2>Aveanna Healthcare 公司簡介</h2>
<p>（獲取免費報告）</p>
<p>Aveanna Healthcare Holdings Inc 是一家多元化的居家護理平台公司，在美國提供兒科和成人醫療服務。其以患者為中心的護理交付平台使患者能夠留在家中，減少高成本護理環境（如醫院或專業護理機構）的過度使用。</p>
<h2>進一步閲讀</h2>
<ul>
<li>我們更看好的五隻股票，而不是 Aveanna Healthcare</li>
<li>什麼是股票市場指數，如何使用它們？</li>
<li>開啓：Applied Digital 的首個 AI 數據中心上線</li>
<li>ETF 支付股息嗎？你需要知道的事項</li>
<li>Alphabet：最有可能主導 2026 年的 AI 領導者</li>
<li>3 只防御類股票將受益於軍事支出增加</li>
<li>2 個理由讓你加倉 Fiserv，1 個理由讓你遠離</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QVZBSA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QVZBSA"/></p>
<p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或評論發送至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資 1,000 美元在 Aveanna Healthcare 嗎？</h2>
<p>在考慮 Aveanna Healthcare 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已經識別出五隻頂級分析師悄悄建議客户現在購買的股票，以便在更廣泛的市場注意到之前……而 Aveanna Healthcare 並不在名單上。</p>
<p>雖然 Aveanna Healthcare 目前在分析師中被評為持有評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

AVAH

<p>Aveanna Healthcare Holdings Inc.（納斯達克代碼：AVAH）獲得了十家研究公司的共識 “持有” 評級。分析師設定的 12 個月平均目標價為 10.1875 美元。最近的分析師行動包括瑞銀集團將目標價上調至 9.50 美元，加拿大皇家銀行上調至 10.00 美元，巴克萊將評級上調至 “增持”，目標價為 9.50 美元，摩根大通將評級上調至 “中性”，目標價為 10.00 美元。此外，內部銷售和機構投資也受到關注，主要股東進行了顯著的股票交易</p>

<p>Shares of Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH - Get Free Report) have been assigned a consensus recommendation of &#34;Hold&#34; from the ten research firms that are covering the stock, Marketbeat Ratings reports. Six analysts have rated the stock with a hold recommendation and four have given a buy recommendation to the company. The average 12-month price target among analysts that have updated their coverage on the stock in the last year is $10.1875.</p>
<div class="lb-trans"><p>Aveanna Healthcare Holdings Inc.（NASDAQ:AVAH - 獲取免費報告）的股票被十家研究公司一致推薦為 “持有”，Marketbeat Ratings 報告稱。六位分析師對該股票給予了持有評級，四位分析師則給予了買入評級。在過去一年中更新了對該股票覆蓋的分析師中，平均 12 個月目標價為 10.1875 美元。</p>
</div><p>A number of analysts recently issued reports on the company. UBS Group raised their price target on Aveanna Healthcare from $9.00 to $9.50 and gave the stock a &#34;neutral&#34; rating in a research report on Friday, November 7th. Royal Bank Of Canada lifted their price target on shares of Aveanna Healthcare from $8.00 to $10.00 and gave the stock a &#34;sector perform&#34; rating in a research note on Friday, October 24th. Barclays upgraded shares of Aveanna Healthcare from an &#34;equal weight&#34; rating to an &#34;overweight&#34; rating and upped their price target for the company from $5.50 to $9.50 in a report on Tuesday, August 19th. JPMorgan Chase &amp; Co. raised Aveanna Healthcare from an &#34;underweight&#34; rating to a &#34;neutral&#34; rating and upped their target price for the company from $6.00 to $10.00 in a research note on Thursday, September 18th. Finally, BMO Capital Markets began coverage on Aveanna Healthcare in a research report on Thursday, November 13th. They set an &#34;outperform&#34; rating and a $11.00 target price for the company.</p>
<div class="lb-trans"><p>最近，一些分析師對該公司發佈了報告。瑞銀集團將 Aveanna Healthcare 的目標價從 9.00 美元上調至 9.50 美元，並在 11 月 7 日的研究報告中給予該股票 “中性” 評級。加拿大皇家銀行在 10 月 24 日的研究報告中將 Aveanna Healthcare 的目標價從 8.00 美元上調至 10.00 美元，並給予該股票 “行業表現” 評級。巴克萊在 8 月 19 日的報告中將 Aveanna Healthcare 的評級從 “持平” 上調至 “超配”，並將該公司的目標價從 5.50 美元上調至 9.50 美元。摩根大通在 9 月 18 日的研究報告中將 Aveanna Healthcare 的評級從 “減持” 上調至 “中性”，並將該公司的目標價從 6.00 美元上調至 10.00 美元。最後，BMO 資本市場在 11 月 13 日的研究報告中開始覆蓋 Aveanna Healthcare，並設定了 “跑贏大盤” 的評級和 11.00 美元的目標價。</p>
</div><p>Get <strong>Aveanna Healthcare</strong> alerts:</p>
<div class="lb-trans"><p>獲取 <strong>Aveanna Healthcare</strong> 的提醒：</p>
</div><p><strong>Check Out Our Latest Stock Report on AVAH</strong></p>
<div class="lb-trans"><p><strong>查看我們最新的 AVAH 股票報告</strong></p>
</div><h2>Insider Buying and Selling</h2>
<div class="lb-trans"><h2>內部買賣</h2>
</div><p>In other news, major shareholder J.H. Whitney Equity Partners V sold 8,346,059 shares of the business's stock in a transaction dated Tuesday, October 21st. The shares were sold at an average price of $9.00, for a total value of $75,114,531.00. Following the completion of the sale, the insider owned 20,544,696 shares in the company, valued at approximately $184,902,264. The trade was a 28.89% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, major shareholder Paul R. Vigano sold 10,000,000 shares of Aveanna Healthcare stock in a transaction that occurred on Tuesday, October 21st. The shares were sold at an average price of $9.00, for a total transaction of $90,000,000.00. Following the transaction, the insider directly owned 386,284 shares in the company, valued at approximately $3,476,556. The trade was a 96.28% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold a total of 32,597,968 shares of company stock valued at $293,381,712 over the last quarter. 7.80% of the stock is owned by corporate insiders.</p>
<div class="lb-trans"><p>在其他消息中，主要股東 J.H. Whitney Equity Partners V 在 10 月 21 日的交易中出售了 8,346,059 股公司的股票。股票以平均價格 9.00 美元出售，總價值為 75,114,531.00 美元。出售完成後，該內部人士在公司中持有 20,544,696 股，估值約為 184,902,264 美元。此次交易使其持股減少了 28.89%。該交易在向 SEC 提交的文件中披露，可以通過此超鏈接訪問。此外，主要股東 Paul R. Vigano 在 10 月 21 日的交易中出售了 10,000,000 股 Aveanna Healthcare 的股票。股票以平均價格 9.00 美元出售，總交易額為 90,000,000.00 美元。交易完成後，該內部人士直接持有 386,284 股，估值約為 3,476,556 美元。此次交易使其持股減少了 96.28%。SEC 對此次出售的文件提供了更多信息。內部人士在上個季度共出售了 32,597,968 股公司股票，價值 293,381,712 美元。公司內部人士持有 7.80% 的股票。</p>
</div><h2>Institutional Inflows and Outflows</h2>
<div class="lb-trans"><h2>機構資金流入和流出</h2>
</div><p>A number of institutional investors and hedge funds have recently modified their holdings of the company. Summit Partners L P acquired a new stake in Aveanna Healthcare in the second quarter worth about $50,477,000. AustralianSuper Pty Ltd acquired a new stake in shares of Aveanna Healthcare during the third quarter worth about $15,743,000. Vanguard Group Inc. increased its stake in shares of Aveanna Healthcare by 34.7% in the third quarter. Vanguard Group Inc. now owns 4,041,659 shares of the company's stock worth $35,850,000 after acquiring an additional 1,041,324 shares during the period. Hillsdale Investment Management Inc. acquired a new stake in Aveanna Healthcare during the 3rd quarter worth about $7,922,000. Finally, Assenagon Asset Management S.A. purchased a new stake in shares of Aveanna Healthcare in the third quarter worth about $7,356,000. Hedge funds and other institutional investors own 87.96% of the company's stock.</p>
<div class="lb-trans"><p>一些機構投資者和對沖基金最近調整了對該公司的持股。Summit Partners L P 在第二季度收購了 Aveanna Healthcare 的新股份，價值約為 50,477,000 美元。AustralianSuper Pty Ltd 在第三季度收購了 Aveanna Healthcare 的股份，價值約為 15,743,000 美元。先鋒集團在第三季度將其在 Aveanna Healthcare 的股份增加了 34.7%。先鋒集團現在持有 4,041,659 股公司的股票，價值為 35,850,000 美元，此前在該期間內又收購了 1,041,324 股。Hillsdale Investment Management Inc.在第三季度收購了 Aveanna Healthcare 的新股份，價值約為 7,922,000 美元。最後，Assenagon Asset Management S.A.在第三季度收購了 Aveanna Healthcare 的股份，價值約為 7,356,000 美元。對沖基金和其他機構投資者持有公司 87.96% 的股票。</p>
</div><h2>Aveanna Healthcare Stock Performance</h2>
<div class="lb-trans"><h2>Aveanna Healthcare 股票表現</h2>
</div><p>Shares of NASDAQ:AVAH opened at $9.32 on Friday. The firm has a fifty day simple moving average of $9.03 and a two-hundred day simple moving average of $6.90. The company has a quick ratio of 1.23, a current ratio of 1.23 and a debt-to-equity ratio of 140.39. The stock has a market capitalization of $1.95 billion, a P/E ratio of 25.88 and a beta of 2.04. Aveanna Healthcare has a 52 week low of $3.67 and a 52 week high of $10.32.</p>
<div class="lb-trans"><p>NASDAQ:AVAH 的股票在週五開盤價為 9.32 美元。該公司的 50 日簡單移動平均為 9.03 美元，200 日簡單移動平均為 6.90 美元。公司的速動比率為 1.23，流動比率為 1.23，債務與股本比率為 140.39。該股票的市值為 19.5 億美元，市盈率為 25.88，貝塔值為 2.04。Aveanna Healthcare 的 52 周最低價為 3.67 美元，52 周最高價為 10.32 美元。</p>
</div><p>Aveanna Healthcare (NASDAQ:AVAH - Get Free Report) last announced its quarterly earnings results on Monday, May 22nd. The company reported $0.04 EPS for the quarter. The firm had revenue of $450.53 million during the quarter. Aveanna Healthcare had a net margin of 3.29% and a negative return on equity of 143.55%. On average, analysts expect that Aveanna Healthcare will post -0.06 earnings per share for the current fiscal year.</p>
<div class="lb-trans"><p>Aveanna Healthcare（NASDAQ:AVAH - 獲取免費報告）最後一次公佈季度財報是在 5 月 22 日，報告顯示該季度每股收益為 0.04 美元。該公司在該季度的收入為 4.5053 億美元。Aveanna Healthcare 的淨利潤率為 3.29%，股本回報率為負的 143.55%。分析師平均預計 Aveanna Healthcare 在當前財年將發佈-0.06 的每股收益。</p>
</div><h2>Aveanna Healthcare Company Profile</h2>
<div class="lb-trans"><h2>Aveanna Healthcare 公司簡介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（獲取免費報告）</p>
</div><p>Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.</p>
<div class="lb-trans"><p>Aveanna Healthcare Holdings Inc 是一家多元化的居家護理平台公司，在美國提供兒科和成人醫療服務。其以患者為中心的護理交付平台使患者能夠留在家中，減少高成本護理環境（如醫院或專業護理機構）的過度使用。</p>
</div><h2>Further Reading</h2>
<div class="lb-trans"><h2>進一步閲讀</h2>
</div><ul>
<li>Five stocks we like better than Aveanna Healthcare</li>
<li>What is a Stock Market Index and How Do You Use Them?</li>
<li>Power On: Applied Digital’s First AI Data Center Goes Live</li>
<li>Do ETFs Pay Dividends? What You Need to Know</li>
<li>Alphabet: The AI Leader Best Positioned to Dominate 2026</li>
<li>3 Defense Stocks Set to Benefit From Increased Military Spending</li>
<li>2 Reasons to Load Up on Fiserv, 1 to Stay Away</li>
</ul>
<div class="lb-trans"><ul>
<li>我們更看好的五隻股票，而不是 Aveanna Healthcare</li>
<li>什麼是股票市場指數，如何使用它們？</li>
<li>開啓：Applied Digital 的首個 AI 數據中心上線</li>
<li>ETF 支付股息嗎？你需要知道的事項</li>
<li>Alphabet：最有可能主導 2026 年的 AI 領導者</li>
<li>3 只防御類股票將受益於軍事支出增加</li>
<li>2 個理由讓你加倉 Fiserv，1 個理由讓你遠離</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QVZBSA" alt="" original-src="https://www.marketbeat.com/scripts/RatingsChart.ashx?Prefix=NASDAQ&amp;Symbol=AVAH"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或評論發送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Aveanna Healthcare Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1,000 美元在 Aveanna Healthcare 嗎？</h2>
</div><p>Before you consider Aveanna Healthcare, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮 Aveanna Healthcare 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aveanna Healthcare wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已經識別出五隻頂級分析師悄悄建議客户現在購買的股票，以便在更廣泛的市場注意到之前……而 Aveanna Healthcare 並不在名單上。</p>
</div><p>While Aveanna Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 Aveanna Healthcare 目前在分析師中被評為持有評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) 被分析師給予平均 “持有” 評級